Mirae Asset Global ETFs Holdings
TNGX icon

Mirae Asset Global ETFs Holdings’s Tango Therapeutics TNGX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.23M Sell
59,537
-3,097
-5% -$43.1K ﹤0.01% 1419
2025
Q4 		$552K Buy
62,634
+22,236
+55% +$192K ﹤0.01% 1839
2025
Q3 		$340K Sell
40,398
-1,600
-4% -$10.8K ﹤0.01% 2047
2025
Q2 		$215K Buy
41,998
+13,360
+47% +$33K ﹤0.01% 2247
2025
Q1 		$39.2K Buy
28,638
+1,227
+4% +$3.01K ﹤0.01% 2887
2024
Q4 		$84.7K Sell
27,411
-2,886
-10% -$13.4K ﹤0.01% 2771
2024
Q3 		$232K Buy
30,297
+4,775
+19% +$45.6K ﹤0.01% 2303
2024
Q2 		$219K Buy
+25,522
New +$197K ﹤0.01% 2203

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TNGX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Tango Therapeutics (TNGX) stake by 4.9% in Q1 2026, selling an estimated $43.1K and leaving 59,537 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1419.

Mirae Asset Global ETFs Holdings first reported a position in TNGX in Q2 2024 and has held it in 8 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 59,537 shares of Tango Therapeutics worth $1.23M as of Q1 2026.
  • Mirae Asset Global ETFs Holdings sold 3,097 Tango Therapeutics shares in Q1 2026, an estimated $43.1K.
  • Tango Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1419 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Tango Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.